Dr. Shrikalp Deshpande,M.Pharm, Ph.D, DBM, MMS, LL.B.
I/c. Principal
Department of Pharmacology and Clinical Pharmacy
Year started @ KBIPER: 1997 to 2006, and rejoined in 2007
Contact info
Location: KBIPER college campus
Email: shrikalp@gmail.com
PhD., Gujarat Univeristy, Ahmedabad, Gujarat
LL.B., Gujarat University, Ahmedabad, Gujarat
M.M.S. (Marketing), Pune University, Pune, Maharashtra
D.B.M. (Marketing), Pune University, Pune, Maharashtra
M.Pharm. (Pharmacology), Pune University, Pune, Maharashtra
B.Pharm., Gujarat University, Ahmedabad, Gujarat
Dr. Shrikalp Deshpande brings with him a total of 20 years of experience in pharmaceutical field including three years in clinical research and regulatory affairs in Pharma R&D at Torrent Research Centre, Gandhinagar. He has also worked in several other areas of pharmaceutical industry like production, quality control and marketing. At academic and research level, he has successfully guided 5 PhD scholars and has guided more than 127 post graduate students of Pharmacology, Clinical Pharmacy, MBA (Pharma) and Pharm D, collectively. He is also been involved in industrial sponsored research work at the institute.
At KBIPER, he is involved in teaching clinical research, regulatory affairs, pharmacotherapeutics, and good clinical practices (GCP). He is also involved in several adminsitrative work at the institute and organising training and workshops on GCP, Biostatistics, Pharmacovigilance, Patent awareness and Clinical Research.
Research area of Interested
Herbal Drugs screening and evaluation, Patient Counseling, CMA, Antibiotic policy, drug Information Centre, Pharmacovigilance, Marketing survey, Product launching
Awards and Recognitions
  1. GUJCOST “Young Scientist Fellowship” from Gujarat Council on Science and Technology, 1999 – 2000.
  2. GUJCOST 2005: for Minor Research Project as Principal Investigator sponsored for “Sub-acute toxicity study of Tephrosia purpurea Linn. Pers, Leptadenia reticulate, Basella rubra.”
  3. AICTE Travel Grant 2008: “Pharmacological activity of Tephrosia purpure” Poster Presentation during 16-20th November 2008 organized by AAPS American Association of Pharmaceutical Scientists at Georgia, Atlanta, USA.
  4. UGC Research AWARD 2011 shortlisted
Memberships (Life members)
  • IPS – Indian Pharmacological Society LD-78
  • IPA – Indian Pharmaceutical Association GUJ/AHM/LM/295
  • APTI Association of Pharmacy Teachers of India GU/LM-065
  • IPGA – Indian Pharmacy Graduate Association LM-GUJ-1297
  • ISP – Indian Society of PharmacognosyLM-103/98
  • LASA – Laboratory Animal Scientists of India
  • SOPI- Society of Pharmacovigilance of India
  • APPI - Association of Pharmacologist and Physicians of India
Selected publications/presentations (Total 26 Publications and 26 Presentations)
  1. Deshpande SS, Shah GB, Parmar NS. Antiulcer activity of Tephrosia purpurea in rats. Indian Journal of Pharmacology. 2003;35(3):168-172.
  2. ) Patel MB, Deshpande SS, Shah GB. Evaluation of Efficacy of Vitamin E and N-Acetyl Cysteine in Gentamicin-Induced Nephrotoxicity in Rats. Ren Fail. 2011;33(3): 341-7.
  3. Ajmera A, Deshpande S, Patel P, Patel K, Solanki S, Rathod K. Reverse phase high performance liquid chromatographic (HPLC) method for simultaneous determination of Atorvastatin, Ezetimibe and Fenofibrate in commercial tablets. Int J Pharm Pharm Sci. 2012;4(1):206-209.
  4. Darji VC, Deshpande SS, Bariya AH. Effect of methanolic extract of Holarrhena antidysentrica bark against experimentally induced inflammatory bowel disease in rats.International Research Journal of Pharmacy IRJP. 2012;3(9):152-154.
  5. ) Shah BS, Deshpande SS. Assessment of demographics, treatment strategies,and evidence-based medicine use among diabetic and non-diabetic patients with acute coronary syndrome: A cohort study. J Pharmacol Pharmacother. 2014 Apr-Jun;5(2):139-144.
  6. Bhavik S, Deshpande S. Assessment of Effect of Diabetes on Health-Related Quality of Life in Patients with Coronary Artery Disease Using EQ-5D Questionnaire. Value in Health Regional Issues. 2014;3:67-72.
  7. Nagar JK, Patel PP, Mohapatra JN, Sharma MM, Pandya GM, Umar MM, Chatterjee AA, Deshpande SS, Jain MR, Soni HM. Differential effects of dexamethasone and rosiglitazone in a sephadex-induced model of lung inflammation in rats: Possible role of tissue inhibitor of metalloproteinase-3. Indian Journal of Pharmacology. 2015;47(2):153-159.